Skip to content

We're in Beta! Found a bug? Let us know using the feedback button at the bottom right.

FolioFact
FolioFact
Q2 2026 58/68 funds filed
Latest observation
Sign in Sign up

Some record dates are in the future and are excluded from the latest observation date.

ARK Investment Management — TEVA

How ARK Investment Management's position in TEVA Pharmaceutical Inds Ltd. changed quarter by quarter. Change badges compare each quarter to the fund's immediately-prior filing.

Quarters held
3
First reported
Q4 2025
Latest value
$2,325,964
Latest weight
0%
Peak weight
0%
Shares since first
-34.7%

Position Trend

Shares, value, and weight from first report to latest report.

ARK Investment Management first reported 105,131 shares in Q4 2025 and most recently reported 68,653 shares in Q2 2026. Portfolio weight peaked at 0% in Q2 2026; the low reported weight was 0% in Q2 2026.

Since the first report, shares are -34.7% and reported value is -29.1%. Latest move: ADD

Quarter Shares Value % of portfolio Change
Q2 2026 68,653 $2,325,964 0.02% ADD
Q1 2026 68,279 $2,056,563 0.02% TRIM
Q4 2025 105,131 $3,281,139 0.02% No prior filing

Send feedback

Optional — tap one if it fits

We'll only use this to respond to your feedback.